The short answer

On 15 May 2026, the Directorate General of Foreign Trade (DGFT) issued a binding notification requiring all Active Pharmaceutical Ingredient (API) exporters to implement digital traceability records—from manufacture through shipment—before clearing consignments. The mandate applies to all IEC holders exporting APIs, whether scheduled or non-scheduled, effective immediately with a 30-day grace window ending mid-June 2026.

Failure to comply triggers customs hold-ups and potential IEC suspension.

Market signals

Digital Batch Documentation Now Mandatory

DGFT requires blockchain-backed or NEFT-integrated batch certificates linking raw materials, manufacturing date, and quality approvals. Manual records or unlinked documentation no longer qualify.

IEC-CDSCO Linkage Enforcement Tightens

All API export consignments must now carry CDSCO pre-approval confirmation embedded in the customs e-bill. Missing linkage results in automatic rejection at port.

Third-Party Manufacturers Face Stricter Audits

Contract manufacturers exporting under client IECs must now register as 'delegated producers' with DGFT and maintain separate traceability logs, adding 4–6 weeks to approval cycles.

◆ What it means for you — the Vinayakam view

This DGFT order directly impacts IEC compliance and export timelines. Businesses must immediately verify their current documentation systems against the new digital-traceability standard and align with CDSCO's approval database before mid-June 2026. Non-compliance will trigger GST input-credit reversal (goods treated as rejected exports) and potential GST notice under Rule 96(4). Vinayakam Consultants' IEC and export-compliance team helps pharma and chemical manufacturers audit existing systems, implement compliant traceability frameworks, and liaise with DGFT and customs to avoid shipment delays and licence penalties.

Your action checklist

  • Audit current batch-documentation and material-tracking systems against DGFT's May 2026 digital-traceability specification by 8 June 2026.
  • Register all contract/third-party manufacturers as 'delegated producers' on the DGFT portal and obtain confirmation before next export shipment.
  • Obtain CDSCO pre-approval confirmation for all scheduled and non-scheduled APIs and embed approval codes in the customs e-bill for each consignment.
  • Conduct dry-run export of one pilot batch under new rules by 10 June 2026 to identify system gaps and allow 5-day remediation window before hard deadline.

Frequently asked questions

What is the DGFT pharma export compliance deadline?

The DGFT mandate issued 15 May 2026 requires all API exporters to implement digital traceability records by mid-June 2026, with a 30-day grace window for compliance.

What happens if I don't comply with DGFT pharma export compliance rules?

Non-compliance triggers customs hold-ups, IEC suspension, GST input-credit reversal, and potential GST notices under Rule 96(4).

Do third-party manufacturers need to register under DGFT rules?

Yes, contract manufacturers exporting under client IECs must register as 'delegated producers' with DGFT and maintain separate traceability logs, adding 4–6 weeks to approval cycles.

API exportDGFT compliancetraceability mandate
Need help acting on this?
Talk to an advisor